Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Using the Drug Spironolactone to Test If It Reduces Protein Leakage From the Kidney

This study has been completed.
Sponsor:
Information provided by:
Melbourne Health
ClinicalTrials.gov Identifier:
NCT00106561
First received: March 25, 2005
Last updated: June 23, 2005
Last verified: March 2005
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: September 2004
  Estimated Primary Completion Date: No date given